SynchNeuro, Inc.
The world’s first non-invasive, brain-based continuous glucose monitor.
health AImedtechwearablesdigital health
StageSeed
Raised$3 million
Founded2021
Employees9
LocationChicago, IL
Business modelB2B2C, partnerships with investors and accelerators (implicit)
About
At SynchNeuro, we are transforming how people monitor and manage their health with the world’s first non-invasive brain-based continuous glucose monitor. Our sensor, discreetly worn behind the ear, analyzes brain signals to track blood glucose levels, sleep quality, and other vital health metrics. This breakthrough technology offers a pain-free, convenient, effective and inexpensive alternative to traditional glucose monitoring methods.
Product
- Value proposition
- Non-invasive brain-based wearable sensor that continuously monitors glucose and metabolic health in real time, providing pain-free, convenient monitoring as an alternative to traditional methods.
- Target customers
- Individuals with prediabetes/diabetes, healthcare providers, researchers, and medtech investors/accelerators
Founders
- Casey Halpern — Co-Founder & Chairman
- Emily Mirro — President & Co-Founder
Categories
MedTechWearable TechnologyDigital HealthComputational NeuroscienceNeuroscience AI
Products
Brainwave sensor (behind-the-ear)EEG-based glucose/metabolic monitoringMachine-learning health analytics
Key features
Non-invasive brain-based continuous glucose monitoringBehind-the-ear wearable sensorReal-time metabolic health metrics including glucose and sleep qualityEEG-based prediction of glucose levelsPain-free, convenient alternative to traditional monitoring
Technologies
EEG/Brain signalsMachine learningWearable sensorsNon-invasive monitoring
Integrations
EHRs / health platforms
Target conditions
PrediabetesDiabetesMetabolic HealthSleep Quality (related metrics)
Care settings
HomeClinicWearable/Personal Monitoring
Certifications
HIPAA (assumed for healthcare data handling, not explicitly stated)
Notable customers
Boomerang Ventures (investor)MedTech Innovator (industry context)Plug and Play Lifetech (accelerator/partner)
Partnerships
Boomerang Ventures (seed funding)Plug and Play Lifetech Indianapolis batch partner
Traction metrics
Seed funding completed (Boomerang Ventures)Participation in incubator/accelerator programsMedia coverage linked in extracted extras
Competitors
Other non-invasive wearables for metabolic monitoring
Investors
Boomerang Ventures
News
- SynchNeuro's CGM Could Measure Glucose Levels Using Brainwaves · 2025-10-27T00:00:00.000Z
- SynchNeuro Has a Working Prototype, a New Study Launching, and a Forecast for Your Blood Sugar | Health Moonshot Update · 2026-05-27T22:02:25.000Z
- SynchNeuro: A Neurosurgeon's Surprising Leap into Cardiometabolic Care — StartUp Health · 2025-06-17T17:30:00.000Z
- SynchNeuro Invents First Non-Invasive, EEG-Based Continuous Glucose Monitor — StartUp Health · 2024-12-13T22:05:22.000Z
- Neurotech Enters Everyday Wellness | Fitt Insider · 2025-11-25T21:06:52.000Z
- Health Transformer Spotlight: Meet Emily Mirro from SynchNeuro, Focused on Innovative Solutions for Individuals with Prediabetes — StartUp Health · 2025-08-07T17:51:22.000Z
Browse similar startups
Related startups
- SynerGen AI — chicago, IL
- VIP Health & Fitness Clinic — Vernon Hills, IL
- WellSaid AI — Northfield, IL
- zuri fertility — chicago, IL
- AccuMix Pharmacy — Elmhurst, IL
- BEST ELDER HOME CARE LLC — Naperville, IL
- Vena Vitals — irvine, CA
- Braveheart Bio — San Francisco, CA
- CareAtlas Inc — Austin, TX
- Corveus Medical — Houston, TX
- Eclipse Regenesis — Menlo Park, CA
- Health Data Max LLC — Arlington, VA
Profile updated Jul 29, 2026. Sources: synchneuro.com
